September 2026
The computational medicine and drug discovery software market size reached USD 12.94 billion in 2026, with leading computational medicine and drug discovery software market companies including Entelos Inc., Crown Bioscience Inc., Chemical Computing Group Inc., Nimbus Therapeutics Inc.
July 2026
The global pharmacovigilance and drug safety software market size was evaluated at USD 2.09 billion in 2025 and is predicted to hit around USD 5.06 billion by 2035, growing at a CAGR of 9.24%.
September 2026
The global drug discovery outsourcing market size was valued at USD 4.78 billion in 2026 and is projected to hit around USD 8.98 billion by 2035 with a CAGR of 7.27%.
September 2026
The global drug discovery market size was evaluated at USD 78.51 billion in 2026 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
September 2026
The drug discovery services market size was estimated at USD 27.89 billion in 2026 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
September 2026
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
September 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.
September 2026
The U.S. drug discovery market generated USD 28.66 billion in 2026, with prominent U.S. drug discovery market companies including Johnson and Johnson, Pfizer Inc., Merck and Co.
September 2026
The CNS drug discovery market was valued at USD 10.86 billion in 2026, with leading companies including Eli Lilly and Company, Roche, Novartis, Pfizer, AbbVie.
September 2026
The drug discovery informatics market size stood at USD 5.35 billion in 2026, with major drug discovery informatics companies including collaborative drug discovery inc, eurofins discoverx products, jubilant biosys, selvita, novo informatics pvt ltd.
July 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
June 2026
The global nuclear medicine software market size is estimated to hit around USD 2,337.15 million by 2035 increasing from USD 978.76 million in 2025, with a CAGR of 9.09%.
May 2026
The global large molecule drug discovery outsourcing market size was evaluated at USD 3.20 billion in 2025 and is predicted to hit around USD 7.67 billion by 2035, growing at a CAGR of 9.14%.
March 2026
The global computer-aided drug discovery market size is projevted to hit around USD 14.38 billion by 2035 from USD 4.72 billion in 2025 with a CAGR of 11.78%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
January 2026
The generative AI in drug discovery market size reached USD 260.56 million in 2025 and is estimated to hit around USD 2,724.15 million by 2035, at a CAGR of 26.45%.
November 2025
The artificial intelligence (AI) in drug discovery market size is predicted to surpass around USD 17.81 billion by 2035 from USD 6.93 billion in 2025 with a solid CAGR of 9.90%.
September 2026
The asthma and COPD drugs market size reached USD 46.93 billion in 2026, with leading asthma and COPD drugs market companies including AstraZeneca, GlaxoSmithKline (GSK), Novartis.
September 2026
The business software and services market size is estimated at USD 744.71 billion in 2026 and is expected to hit around USD 1,833.36 billion by 2034, with a strong CAGR of 11.92%.
September 2026
The global head and neck cancer drugs market size surpassed USD 20.09 billion in 2026 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
September 2026
The global drug and gene delivery devices market size is projected to hit around USD 1,875.96 million by 2035 from USD 864.96 million in 2026, with a CAGR of 9.00%.
September 2026
The global complementary and alternative medicine market size is valued at USD 241.70 billion in 2026 and is expected to hit around USD 1,412.89 billion by 2035 with a CAGR of 22.00%.
September 2026
The global medical device vigilance and patient safety software market size was evaluated at USD 1.56 billion in 2026 and is predicted to hit around USD 4.23 billion by 2035, growing at a CAGR of 11.70%.
September 2026
The project and portfolio management software market size reached USD 6.90 billion in 2026, with leading project and portfolio management software market companies including Microsoft, Oracle, SAP, Smartsheet.
September 2026
The global behavioral and mental health software market size was estimated at USD 8.79 billion in 2026 and is predicted to reach around USD 30.62 billion by 2034, at a CAGR of 16.98%.
September 2026
The global insulin drugs and delivery devices market size is evaluated at USD 27.47 billion in 2026 and is predicted to hit around USD 52.72 billion by 2035, growing at a CAGR of 7.52%.
September 2026
By Gautam Mahajan - Aug 2026 - AI for energy optimization software market was valued at USD 4.92 billion in 2026, expanding at a CAGR of 19.38% by 2035.
August 2026
The pulmonary alveolar proteinosis (PAP) drugs market reached USD 859.05Â million in 2026, with key pulmonary alveolar proteinosis (PAP) drugs market companies including Savara, Inc., Partner Therapeutics, Inc., Nobelpharma Co., Ltd. Amgen Inc
July 2026
The global endoscopy equipment and software market size was evaluated at USD 53.82 billion in 2025 and is predicted to hit around USD 112.26 billion by 2035, growing at a CAGR of 7.63%.
May 2026
The global pharmacy inventory management software solutions and cabinet market size is estimated to hit around USD 15.23 billion by 2035 from USD 7.72 billion in 2026, at a CAGR of 7.85%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com